Literature DB >> 23568440

Growth hormone in health and disease: Prader-Willi syndrome--GH therapy and bone.

Graziano Grugni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23568440     DOI： 10.1038/nrendo.2013.74

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Muscle-bone characteristics in children with Prader-Willi syndrome.

Authors:  Thomas Edouard; Cheri Deal; Guy Van Vliet; Natacha Gaulin; Alain Moreau; Frank Rauch; Nathalie Alos
Journal:  J Clin Endocrinol Metab       Date:  2011-12-07       Impact factor: 5.958

2.  The GH/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome.

Authors:  I C van Nieuwpoort; M Sinnema; J A Castelijns; J W R Twisk; L M G Curfs; M L Drent
Journal:  Horm Res Paediatr       Date:  2011-01-27       Impact factor: 2.852

3.  Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD.

Authors:  A P Jørgensen; T Ueland; R Sode-Carlsen; T Schreiner; K F Rabben; S Farholt; C Høybye; J S Christiansen; J Bollerslev
Journal:  J Clin Endocrinol Metab       Date:  2013-02-22       Impact factor: 5.958

4.  Prader-Willi Syndrome: clinical concerns for the orthopaedic surgeon.

Authors:  Leo T Kroonen; Martin Herman; Peter D Pizzutillo; G Dean Macewen
Journal:  J Pediatr Orthop       Date:  2006 Sep-Oct       Impact factor: 2.324

5.  Effect of ghrelin on bone mass density: the InChianti study.

Authors:  Nicola Napoli; Claudio Pedone; Paolo Pozzilli; Fulvio Lauretani; Stefania Bandinelli; Luigi Ferrucci; Raffaele Antonelli Incalzi
Journal:  Bone       Date:  2011-04-09       Impact factor: 4.398

Review 6.  Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis.

Authors:  Emmanuel Biver; Carine Salliot; Christophe Combescure; Laure Gossec; Pierre Hardouin; Isabelle Legroux-Gerot; Bernard Cortet
Journal:  J Clin Endocrinol Metab       Date:  2011-07-21       Impact factor: 5.958

7.  Bone mineral density and effects of growth hormone treatment in prepubertal children with Prader-Willi syndrome: a randomized controlled trial.

Authors:  Roderick F A de Lind van Wijngaarden; Dederieke A M Festen; Barto J Otten; Edgar G A H van Mil; Joost Rotteveel; Roelof J Odink; Mariëtte van Leeuwen; Danny A J P Haring; Gianni Bocca; E C A Mieke Houdijk; Anita C S Hokken-Koelega
Journal:  J Clin Endocrinol Metab       Date:  2009-07-21       Impact factor: 5.958

8.  Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood.

Authors:  Muriel Coupaye; Françoise Lorenzini; Célia Lloret-Linares; Catherine Molinas; Graziella Pinto; Gwenaëlle Diene; Emmanuelle Mimoun; Geneviève Demeer; Florence Labrousse; Joseba Jauregi; Virginie Laurier; Arnaud Basdevant; Michel Polak; Denise Thuilleaux; Maïthé Tauber; Christine Poitou
Journal:  J Clin Endocrinol Metab       Date:  2013-01-02       Impact factor: 5.958

9.  Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH+arginine in Prader-Willi adults and obese controls.

Authors:  Graziano Grugni; Eleonora Marostica; Antonino Crinò; Paolo Marzullo; Giuseppe De Nicolao; Alessandro Sartorio
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04-05       Impact factor: 3.478

Review 10.  Prader-Willi syndrome.

Authors:  Suzanne B Cassidy; Stuart Schwartz; Jennifer L Miller; Daniel J Driscoll
Journal:  Genet Med       Date:  2011-09-26       Impact factor: 8.822
  10 in total
  2 in total

Review 1.  Growth hormone therapy for Prader-willi syndrome: challenges and solutions.

Authors:  Graziano Grugni; Alessandro Sartorio; Antonino Crinò
Journal:  Ther Clin Risk Manag       Date:  2016-06-02       Impact factor: 2.423

2.  Circulating microRNA Associated to Different Stages of Liver Steatosis in Prader-Willi Syndrome and Non-Syndromic Obesity.

Authors:  Muhammad Yogi Pratama; Devis Pascut; Sofia Tamini; Alessandro Minocci; Claudio Tiribelli; Graziano Grugni; Alessandro Sartorio
Journal:  J Clin Med       Date:  2020-04-14       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.